STML

Stemline Therapeutics, Inc.
STML

Overview Fund Activity
Delisted

STML was delisted on the 9th of June, 2020.

Back to rankings

74 hedge funds and large institutions have $104M invested in Stemline Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 30 increasing their positions, 15 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
+5
Holders Change %
+7.25%
% of All Funds
1.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
30
Reduced
15
Closed
8
Calls
$690K
Puts
$344K
Net Calls
+$346K
Net Calls Change
+$264K

Top Buyers

1
SM
1
Sabby Management
Florida
$3.83M
2
FCM
2
Farallon Capital Management
California
$2.76M
3
JGC
3
J. Goldman & Co
New York
$2.14M
4
Millennium Management
4
Millennium Management
New York
$1.76M
5
BIM
5
Bogle Investment Management
Massachusetts
$1.02M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$15.8M
2
Franklin Resources
2
Franklin Resources
California
$15.5M
3
RA
3
Royce & Associates
New York
$0
4
CCI
4
Columbus Circle Investors
$1.05M
5
Mackenzie Financial
5
Mackenzie Financial
Ontario, Canada
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TC
76
TFS Capital
Pennsylvania
– -$253K -23,324 Closed
SOMRS
77
State of Michigan Retirement System
Michigan
– -$217K -20,000 Closed
Goldman Sachs
78
Goldman Sachs
New York
– -$132K -12,158 Closed
EWM
79
Edge Wealth Management
New York
– -$22K -2,000 Closed
Simplex Trading
80
Simplex Trading
Illinois
– -$7K -671 Closed
PCM
81
Prelude Capital Management
New York
– -$1K -100 Closed
1 2 3
4